Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cyberkinetics Neurotechnology Systems
Spaulding Rehabilitation joins BrainGate Neural Interface System pilot study
January 9th, 2005
The Spaulding Rehabilitation Hospital (Spaulding) and Cyberkinetics Neurotechnology Systems, Inc. (CYKN) announced the addition of Spaulding as a new clinical site for the BrainGate Neural Interface System pilot study. Spaulding, a teaching affiliate of Harvard Medical School, is a premier rehabilitation facility in the United States and the second rehabilitation center to participate in the study. Cyberkinetics received regulatory clearance from the U.S. Food and Drug Administration (FDA) in March of 2004 to study the BrainGate Neural Interface System under an Investigational Device Exemption (IDE). In the first several weeks of...
Source: Aging & Elder Health Week (2005-01-09)
|
